comparemela.com
Home
Live Updates
Ligand Fourth Quarter - Breaking News
Pages:
Latest Breaking News On - Ligand fourth quarter - Page 1 : comparemela.com
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q4 2023 Earnings Call Transcript
Ligand Pharmaceuticals Incorporated beats earnings expectations. Reported EPS is $1.03, expectations were $0.58.
United states
Tavo espinoza
Amgen kyprolis
Todd davis
Paul hadden
Matt hewitt
Matthew korenberg
Lawrence solow
Primrose bio
Merck vaxneuvance
Karen reeves
Mattew korenberg
Matt korenberg
Jazz pharmaceuticals
Exchange commission
Craig hallum capital group
vimarsana © 2020. All Rights Reserved.